- Research works
- 116 ▼ 6% vs 2013–17
- Citations
- 4.7k 40.3 per fractional work
- Top-10% rate
- 19.9% record average 16.5%
- Open access
- 41% world 28%
Not ranked overall: European Society for Blood and Marrow Transplantation is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.8×. Every wedge is a field page.
- Medicine 3.8×
- Immunology and Microbiology 3.4×
- Biochemistry, Genetics and Molecular Biology 1.0×
- Physics and Astronomy 0.8×
- Social Sciences 0.7×
- Health Professions 0.5×
- Chemistry 0.4×
- Engineering 0.3×
- Neuroscience 0.2×
- Materials Science 0.2×
- Dentistry 0.1×
- Economics, Econometrics and Finance 0.1×
- Computer Science 0.1×
- Psychology 0.1×
- Agricultural and Biological Sciences 0.0×
- Environmental Science 0.0×
Which keywords describe research at European Society for Blood and Marrow Transplantation?
By fractional works in all years, weighted toward what it does more of than the world: Hematopoietic Stem Cells, Prognostic Factors, Mesenchymal Stem Cells, Bone Marrow Niche, Graft-versus-Host Disease, Minimal Residual Disease, Acute Myeloid Leukemia and AML.
- Polyomavirus
- Chimeric Antigen Receptor
- Autoimmunity
- Immunomodulation
- Regeneration
- Leukemia
- Chronic Lymphocytic Leukemia
- Therapeutic Targets
- Transplantation
- Hodgkin's Lymphoma
- Gene Expression Profiling
- Classification
- Immunotherapy
- BCR-ABL
- Rituximab
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Minimal Residual Disease
- Bone Marrow Niche
- Prognostic Factors
- Hematopoietic Stem Cells
- Mesenchymal Stem Cells
- Graft-versus-Host Disease
- AML
- Genetic Alterations
- Childhood Cancer
- Lymphoma
- Imatinib
- Chemotherapy
- PET Imaging
- Genetic Pathogenesis
- Molecular Profiling
- Immunosuppression
- Cancer Immunotherapy
- Genomic Aberrations
- Differentiation
- Stromal Cells
- Multipotent
- CAR T Cells
- Merkel Cell Carcinoma
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Hematopoietic Stem Cells28▲ 242×3 topics
- Prognostic Factors23▲ 43×11 topics
- Mesenchymal Stem Cells22▲ 158×3 topics
- Bone Marrow Niche19▲ 485×1 topic
- Graft-versus-Host Disease19▲ 485×1 topic
- Minimal Residual Disease10▲ 125×2 topics
- AML9▲ 170×1 topic
- Acute Myeloid Leukemia9▲ 170×1 topic
- Genetic Alterations9▲ 106×2 topics
- Acute Lymphoblastic Leukemia8▲ 202×1 topic
- Childhood Cancer8▲ 202×1 topic
- Rituximab7▲ 40×4 topics
- Lymphoma7▲ 40×4 topics
- BCR-ABL5▲ 141×1 topic
- Imatinib5▲ 141×1 topic
- Immunotherapy5▲ 6.0×9 topics
- Chemotherapy4▲ 5.4×20 topics
- Classification4▲ 10×2 topics
- PET Imaging4▲ 17×3 topics
- Gene Expression Profiling4▲ 36×2 topics
- Genetic Pathogenesis4▲ 58×1 topic
- Hodgkin's Lymphoma4▲ 58×1 topic
- Molecular Profiling4▲ 29×2 topics
- Transplantation4▲ 28×4 topics
- Immunosuppression4▲ 26×4 topics
- Therapeutic Targets4▲ 13×2 topics
- Cancer Immunotherapy3▲ 21×3 topics
- Chronic Lymphocytic Leukemia3▲ 58×1 topic
- Genomic Aberrations3▲ 58×1 topic
- Leukemia3▲ 37×2 topics
- Differentiation3▲ 32×2 topics
- Regeneration3▲ 13×2 topics
- Stromal Cells3▲ 26×2 topics
- Immunomodulation3▲ 15×1 topic
- Multipotent3▲ 58×1 topic
- Autoimmunity2▲ 9.9×3 topics
- CAR T Cells2▲ 44×1 topic
- Chimeric Antigen Receptor2▲ 44×1 topic
- Merkel Cell Carcinoma2▲ 89×1 topic
- Polyomavirus2▲ 89×1 topic
Which research topics does European Society for Blood and Marrow Transplantation publish most on?
By volume in 2022–2025: Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research and CAR-T cell therapy research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Hematopoietic Stem Cell Transplantation Hematology 2 works
- 2 Acute Myeloid Leukemia Research Hematology 2 works
- 3 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 1 works
- 4 CAR-T cell therapy research Oncology 1 works
- 5 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
- 6 Education, sociology, and vocational training Sociology and Political Science 0 works
- 7 Polyomavirus and related diseases Oncology 0 works
- 8 Chronic Myeloid Leukemia Treatments Hematology 0 works
- 9 Law in Society and Culture Law 0 works
- 10 Historical Legal Studies and Society Political Science and International Relations 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has European Society for Blood and Marrow Transplantation's research output changed?
Output in 2018–2022 was 6% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Paris
- Centre National de la Recherche Scientifique
- Inserm
- Sorbonne Université
- Université Paris Cité
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives
- Université Paris 1 Panthéon-Sorbonne
- Institut Pasteur
- Assistance Publique – Hôpitaux de Paris
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.